Profile:
Elite Pharmaceuticals Inc.
165 Ludlow Avenue
Northvale, NJ 07647
United States - Map
Phone: 201-750-2646
Fax: 201-750-2755
Website: http://www.elitepharma.com
Details
Index Membership: N/A
Sector: Healthcare
Industry: Drug Manufacturers - Other
Full Time Employees: 16
Business Summary
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and license of orally administered controlled release drug delivery systems and products in the United States. The company focuses on developing products that cover therapeutic areas for pain, allergy, and infection. It offers two once-daily allergy products, including Lodrane 24 and Lodrane 24D. The company’s products under development comprise ELI-216, an abuse resistant oxycodone product; and ELI-154, a once-a-day oxycodone product. It also involves in contract research and development operations on behalf of other pharmaceutical companies. Elite Pharmaceuticals has a strategic alliance agreement with Epic Pharma, LLC and Epic Investments, LLC. The company was founded in 1984 and is based in Northvale, New Jersey.
Business Overview
BRIEF: For the nine months ended 31 December 2010, Elite Pharmaceuticals, Inc.'s revenues increased 22% to $3.1M. Net income totaled $3M vs. a loss of $12.1M. Revenues reflect an increase in royalties received, higher manufacturing fees received and the presence of lab fee revenue. Net income reflects a decrees in cost of revenue, a significant increase in the gross profit margin and the presence of gain from change in fair value of preferred derivatives. http://www.elitepharma.com/
Missed a nice run up...let's watch for a pull back,
just may be good for a buy.
See the insider trading and you will see that the company is purchasing which is a good sign.
Good looking chart !
Day's Range: 0.1950 - 0.2190
52wk Range: 0.04 - 0.26
Volume: 7,670,570
Avg Vol (3m): 6,979,270
Market Cap: 23.03M
P/E (ttm): 6.78
EPS (ttm): 0.03
Div & Yield: N/A (N/A)
Technicals
Most Actives
Percentage Gainer
Last Price Quote is:
31.01%above 13-day EMA
114.77%above 50-day EMA
RS Rating: N/A
Headlines...
http://finance.yahoo.com/q/h?s=ELTP.OB&t=2011-04-07T08:14:30-04:00